-
Aurobindo receives approval for generic Razadyne, Monopril
HYDERABAD, India — Indian generic drug maker Aurobindo has received two approvals from the Food and Drug Administration.
The company said Wednesday that it received approval for galantamine tablets in the 4-, 8- and 12-mg strengths. The drug is a version of Johnson & Johnson’s Alzheimer’s treatment Razadyne; various versions of the drug had sales of $41 million during the 12 months ended in September 2010, according to IMS Health.
-
NCPA: Florida bill sacrifices indie pharmacy in war on drugs
ALEXANDRIA, Va. — The National Community Pharmacists Association on Thursday spoke out against a Florida bill sponsored by state Rep. Rob Schenck, R-District 44, which would restrict the dispensing of controlled substances on Schedule II and III to publicly traded pharmacy chains and pharmacies that have more than $100 million in taxable revenues, or only those independent community pharmacies that have been in business more than 10 years.